36 results on '"Perol, M."'
Search Results
2. Perceptions et connaissances sur le cancer du poumon en France : une enquête en regards croisés auprès du grand public et des médecins
3. PL02.05 IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
4. Actinomycose bronchique pseudo-tumorale simulant une ré-évolution d’un cancer bronchique 14ans après la prise en charge thérapeutique initiale : à propos d’un cas
5. 186TiP An open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)
6. OA04.05 Trastuzumab Deruxtecan in HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Interim Results of DESTINY-Lung01
7. Efficacité du Pembrolizumab en première ligne chez les patients avec cancer du poumon non à petites cellules, non épidermoïdes, métastatiques, PDL1>50 % avec mutation KRAS G12C (étude ESCKEYP–GFPC 05–2018)
8. Efficacité et tolérance de l’immunothérapie par anti-PD1/PDL1 dans le CBNPC métastatique avec mutation BRAF, HER2 ou MET, amplification MET ou translocation RET. GFPC 01-2018
9. Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial
10. Decreased production of local immunoglobulin A to Pneumocystis carinii in bronchoalveolar lavage fluid from human immunodeficiency virus-positive patients.
11. Decreased Production of Local Immunoglobulin A toPneumocystis cariniiin Bronchoalveolar Lavage Fluid from Human Immunodeficiency Virus-Positive Patients
12. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results
13. Exploratory analyses of surrogate endpoints in metastatic non-small cell lung cancer
14. The limits of chemotherapy dose intensification using Granulocyte Colony Stimulating Factor alone in extensive small cell lung cancer
15. Pulmonary function tests after radiation therapy following pneumonectomy
16. Cost analysis of hospital treatment - two chemotherapic for non-surgical non-small cell lung cancer
17. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer
18. ES01.04 Immunotherapy, Radiotherapy and Chemotherapy Combination: A Potential New Standard?
19. P1.04-30 Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance
20. P1.01-124 Health-Related Quality of Life (HRQoL) Data in a Phase 3 Study of First-Line Brigatinib vs Crizotinib in NSCLC (ALTA-1L)
21. MA11.03 Trastuzumab Deruxtecan in HER2-Mutated Metastatic Non-Small Cell Lung Cancer (NSCLC): Interim Results of DESTINY-Lung01
22. Does Age Play a Role in Clinical Presentation of Hypothyroidism?
23. Peripheral venous catheter embolism
24. Pathologie pulmonaire infiltrative diffuse survenant chez des patients traités par les inhibiteurs des points de contrôle immunitaire (immunothérapie)
25. P1.01-116 Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC
26. MA21.07 Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
27. MA07.05 Immune Checkpoint Inhibitor (ICPi) Re-Challenge: Outcomes Analysis in a French National Cohort of Non-Small-Cell Lung Cancer (NSCLC) Patients
28. 168P Real life practice of gefitinib in patients (pts) with non-small-cell lung cancer (NSCLC) depending on epidermal growth factor receptor (EGFR) mutation status: Results from the prospective EPIDAURE study
29. Données en « vraie vie » de patients traités par gefitinib pour un cancer bronchique non à petites cellules localement avancé ou métastatique, avec mutation de l’EGFR : résultats de l’étude EPIDAURE
30. Phase II with Taxol (Paclitaxel) (T), Carboplatin (C) and brain radiotherapy (RT) in patients (PTS) with inoperable brain metastases (BM) of non-small cell lung cancer (NSCLC)
31. Conformal radiotherapy as an alternative to surgery for respiratory inoperable stage I non-small cell lung cancer (NSCLC)
32. Phase II trial of high dose chemotherapy with amifostine and concurrent irradiation in limited disease small cell lung cancer (SCLC)
33. Place of surgery in the treatment of small cell lung carcinoma. Report of a serie of 27 patients
34. Multicenter randomized phase II trial assessing docetaxel (D) alternating with cisplatin (C) and vinorelbine (V) versus cisplatin (C) - vinorelbine (V) in stage IV non-small-cell lung cancer (NSCLC)
35. 93 HDR brachytherapy alone or associated with external irradiation in treatment of endobronchial cancer : A retrospective study of 60 patients in Centre Leon Bérard
36. 1081 Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.